SAN FRANCISCO, Nov. 21, 2018 /PRNewswire/ -- Arterys, the leader in intelligent, 100% web-based medical imaging software, will demonstrate its wide-ranging suite of AI powered solutions that support fast, efficient and accurate analysis of medical images at RSNA 2018 (North Hall, Booth 7964), November 25-30 in Chicago.
Driven by deep learning and cloud computation, the Arterys platform opens a new era for medical imaging and clinical diagnosis with the power of the internet to enhance clinician workflow, streamlining and speeding analysis of breast, heart, liver and lung images to deliver improved patient outcomes for key workflows.
"Arterys is taking medical imaging analysis to new heights with a powerful U.S. FDA-cleared system that makes it easier for clinicians to detect and diagnose tumors and heart problems," said Arterys CEO Fabien Beckers. "We are excited to highlight our latest advancements and demonstrate multiple web-based solutions for the radiology community, and to sponsor the Machine Learning Showcase at RSNA."
Arterys will provide demonstrations of its AI-powered, web-based solutions, including:
The Arterys HIPAA- and EU GDPR-compliant solutions integrate with existing electronic health records (EHRs), PACS and RIS environments and dictation solutions.
All demonstrations will take place in Arterys booth (North Hall, Booth 7964), located within the Machine Learning Pavilion.
Arterys CEO Fabien Beckers, along with Michael Poon, MD, Northwell Health cardiologist, will present "The Potential of a Web Platform to Transform Medical Imaging with AI and Cloud Computation" in the RSNA Machine Learning Showcase, Tuesday November 27 at 11:30am CST.
About Arterys, Inc.
Arterys was founded in 2011 to facilitate the global advancement of healthcare and enable data driven medicine by leveraging cloud computation and artificial intelligence. Its first major milestone was the first-ever clearance of cloud-based deep learning software for clinical use. Arterys offers a suite of applications for clinicians on the Arterys network via its cloud-based, web-enabled AI medical imaging platform. MICA enables use and interaction with deep learning algorithms in real time, augmenting the clinician and expediting image interpretation.
The company's goal is to reduce variability and subjectivity in clinical diagnoses, and alleviate the enormous workloads radiologists face. With AI, the company is improving the accuracy and consistency in imaging interpretation across practices. Arterys is now leveraging its medical imaging platform to expanding its technology beyond Cardiac MR to create other imaging applications to make medical imaging services vastly more automated, quantitative and useful.
*Semi-quantitative perfusion and quantitative delayed enhancement analysis for Cardio AI are for research only in the US due to contrast agents used.
SOURCE Arterys, Inc.